Corpus Intelligence EBITDA Bridge — MORRISON COMMUNITY HOSPITAL 2026-04-27 12:06 UTC
EBITDA Bridge — MORRISON COMMUNITY HOSPITAL
CCN 141329 | IL | 25 beds | Current EBITDA $11.8M → Pro Forma $14.6M (+$2.8M)
🛡️ Public data only — no PHI permitted on this instance.
EBITDA BRIDGE  ·  CCN 141329

MORRISON COMMUNITY HOSPITAL
value-creation walk.

7-lever RCM bridge from current EBITDA to pro-forma — denial / underpay / DAR / coding / contract / cost discipline / cash acceleration. Each lever shows current vs benchmark target with data provenance.

$53.2M
Net Revenue HCRIS
$11.8M
Current EBITDA COMPUTED
+$2.8M
RCM EBITDA Uplift
$14.6M
Pro Forma EBITDA
+526bps
Margin Improvement
$2.0M
WC Released (1x)

Bridge Realization Estimate

ML model predicts what fraction of the bridge is achievable (accuracy: 60%, n=5,839)

62%
Realization (C)
$2.8M
Modeled Uplift
$1.7M
Risk-Adjusted
-$1.1M
Execution Discount
Occupancy RateLower Occupancy Rate reduces execution likelihood
Bed CountHigher Bed Count increases execution likelihood
Revenue per BedHigher Revenue per Bed increases execution likelih
Commercial Payer %Higher Commercial Payer % increases execution like
Net-to-Gross RatioHigher Net-to-Gross Ratio reduces execution likeli

Expected realization: 62% of modeled bridge. Strengths: Bed Count, Revenue per Bed. Risks: Occupancy Rate, Net-to-Gross Ratio. Risk-adjusted uplift: $1.7M (vs $2.8M modeled).

EBITDA Bridge — 7 RCM Levers

Each bar shows the annual EBITDA impact at full run-rate. Revenue levers increase top-line; cost levers reduce operating expense; cash acceleration releases working capital. Calibrated to published research bands (Denial 12%→5% = $8-15M on $400M NPR).

Cost to Collect
Cost Savings | 12mo ramp
$1.1M
+200bp
Denial Rate Reduction
Revenue | 12mo ramp
$1.1M
+198bp
A/R Days Reduction
Cash Accel | 9mo ramp
$647K
+122bp
Clean Claim Rate
Cost Savings | 6mo ramp
$34K
+6bp
Total EBITDA Impact$2.8M

Lever Detail

Each value shows its data source. SELLER = seller data room, DEFAULT = model default, BENCHMARK = P75 peer benchmark.

LeverCurrentTargetRevenueCostEBITDAWCRamp
Cost to Collect4.5% DEFAULT2.5% BENCHMARK$0$1.1M$1.1M$012mo
Denial Rate Reduction12.0% DEFAULT6.5% BENCHMARK$1.0M$29K$1.1M$012mo
A/R Days Reduction52.00 DEFAULT38.00 BENCHMARK$163K$484K$647K$2.0M9mo
Clean Claim Rate88.0% DEFAULT96.0% BENCHMARK$0$34K$34K$06mo
Net Collection Rate93.5% DEFAULT48.8% BENCHMARK$0$0$0$018mo
CDI / Case Mix Index135.0% DEFAULT142.0% BENCHMARK$0$0$0$018mo

Implementation Timing Curve

Linear ramp to full run-rate per lever. Month 0 = close date. Partners should expect 60-70% of total uplift realized by month 12.

LeverM0M3M6M9M12M18M24M36
Cost to Collect$0$266K$532K$798K$1.1M$1.1M$1.1M$1.1M
Denial Rate Reduction$0$263K$527K$790K$1.1M$1.1M$1.1M$1.1M
A/R Days Reduction$0$216K$431K$647K$647K$647K$647K$647K
Clean Claim Rate$0$17K$34K$34K$34K$34K$34K$34K
Cumulative$0$762K$1.5M$2.3M$2.8M$2.8M$2.8M$2.8M

Returns Sensitivity (IRR / MOIC)

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Green = exceeds 20% IRR hurdle. Amber = 15-20%. Red = below hurdle or loss. RCM uplift of $2.8M is added at exit.

Entry \ Exit9.0x10.0x11.0x11.5x12.0x
8.0x47% / 7.0x52% / 8.1x56% / 9.2x58% / 9.8x60% / 10.4x
9.0x42% / 5.8x47% / 6.8x51% / 7.8x53% / 8.3x55% / 8.8x
10.0x38% / 4.9x42% / 5.8x46% / 6.7x48% / 7.2x50% / 7.6x
11.0x33% / 4.2x38% / 5.0x42% / 5.8x44% / 6.2x46% / 6.7x
12.0x29% / 3.6x34% / 4.3x38% / 5.1x40% / 5.5x42% / 5.8x

Covenant Headroom (at 10x Entry, 6.5x Max Leverage)

8.5x
Entry Leverage
6.8x
Pro Forma Leverage
-0.3x
Headroom (turns)
-5%
EBITDA Cushion

Pro forma EBITDA can decline -5% before the 6.5x covenant trips. RCM uplift reduces leverage from 8.5x to 6.8x, adding 1.6 turns of cushion.

5-Year Value Creation Waterfall

EBITDA trajectory: 3% organic growth + RCM uplift ramp (full run-rate at month 18).

Base EBITDARCM UpliftTotalMargin
Entry$11.8M$11.8M22.2%
Year 1$12.2M+$1.9M$14.0M26.4%
Year 2$12.5M+$2.8M$15.3M28.8%
Year 3$12.9M+$2.8M$15.7M29.5%
Year 4$13.3M+$2.8M$16.1M30.3%
Year 5$13.7M+$2.8M$16.5M31.0%
$118.1M
Entry EV (10x)
$181.4M
Exit EV (11x)
$63.3M
Value Created
$16.5M
Exit EBITDA
$18.8M
Organic Growth
$28.0M
RCM Value Creation
$16.5M
Multiple Expansion

Achievement Sensitivity

What if we only achieve a fraction of each lever? 50% = conservative, 75% = base management case, 100% = plan, 120% = stretch.

Lever50%75%100%120%
Cost to Collect$532K$798K$1.1M$1.3M
Denial Rate Reductio$527K$790K$1.1M$1.3M
A/R Days Reduction$324K$485K$647K$777K
Clean Claim Rate$17K$26K$34K$41K
Total$1.4M$2.1M$2.8M$3.4M

Peer Context — Where This Hospital Sits

Key metrics vs 75 size-matched peers. Low percentile on margin/efficiency metrics = more room for improvement = larger bridge opportunity.

MetricHospitalP25P50P75Percentile
Op Margin22.2%-7.4%-1.9%5.7%
P95
Net-to-Gross63.3%33.4%42.5%48.7%
P96
Occupancy19.5%17.4%26.2%40.8%
P29
Rev/Bed$2.1M$1.1M$1.5M$2.0M
P75
Exp/Bed$1.7M$1.2M$1.5M$2.0M
P59

Bridge Methodology

Coefficients calibrated to published research bands: denial 12%→5% = $8-15M on $400M NPR. Current metrics estimated from HCRIS public data and ML predictions. Target metrics set at P75 peer benchmarks with 60% gap closure assumption. Revenue levers use NPR × delta × avoidable share. Cost levers use claims volume × cost per reworked claim. Working capital from AR reduction is one-time cash (not included in recurring EBITDA). Returns assume 5.5x leverage, 3% organic growth, 10%/yr debt paydown.

Data: HCRIS FY2022 | 6,123 hospitalsSources: HCRISML